Vargese SS, Dev SS, Soman S, Kurian N, Mathew E (2022) Exposure risk and COVID-19 infection among frontline health-care workers: a single tertiary care centre experience. Clin Epidemiol Glob Health 13:100933

Article  CAS  PubMed  Google Scholar 

Zhou Q, Gao Y, Wang X, Liu R, Du P, Wang X, Zhang X, Lu S, Wang Z, Shi Q (2020) Nosocomial infections among patients with COVID-19, SARS and MERS: a rapid review and meta-analysis. Ann Transl Med 8(10):629

Article  CAS  PubMed  PubMed Central  Google Scholar 

Evans S, Agnew E, Vynnycky E, Stimson J, Bhattacharya A, Rooney C, Warne B, Robotham J (2021) The impact of testing and infection prevention and control strategies on within-hospital transmission dynamics of COVID-19 in English hospitals. Philos Trans R Soc B 376:20200268

Article  CAS  Google Scholar 

Olmos C, Campaña G, Monreal V, Pidal P, Sanchez N, Airola C, Sanhueza D, Tapia P, Muñoz AM, Corvalan F (2021) SARS-CoV-2 infection in asymptomatic healthcare workers at a clinic in Chile. PLoS ONE 16:e0245913

Article  CAS  PubMed  PubMed Central  Google Scholar 

Polack FP, Thomas SJ, Kitchin N, Absalon J, Gurtman A, Lockhart S, Perez JL, Pérez Marc G, Moreira ED, Zerbini C (2020) Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine. N Engl J Med 383:2603–2615

Article  CAS  PubMed  Google Scholar 

Angel Y, Spitzer A, Henig O, Saiag E, Sprecher E, Padova H, Ben-Ami R (2021) Association between vaccination with BNT162b2 and incidence of symptomatic and asymptomatic SARS-CoV-2 infections among health care workers. JAMA 325:2457–2465

Article  CAS  PubMed  Google Scholar 

Acharya CB, Schrom J, Mitchell AM, Coil DA, Marquez C, Rojas S, Wang CY, Liu J, Pilarowski G, Solis L (eds) (2022) Viral load among vaccinated and unvaccinated, asymptomatic and symptomatic persons infected with the SARS-CoV-2 Delta variant. Open forum infectious diseases. Oxford University Press US.

Zuin M, Gentili V, Cervellati C, Rizzo R, Zuliani G (2021) Viral load difference between symptomatic and asymptomatic COVID-19 patients: systematic review and meta-analysis. Infect Dis Rep 13:645–653

Article  PubMed  PubMed Central  Google Scholar 

15th National Technical Advisory Group on Immunization (NTAGI) (2022) https://main.mohfw.gov.in/sites/default/files/MoM%20NTAGI%20%20May%2028%2C%202021.pdf. Accessed 30 Aug 2022

Strategies to mitigate healthcare personnel staffing shortages (2021) https://www.cdc.gov/coronavirus/2019-ncov/hcp/mitigating-staff-shortages.html. Accessed 30 Aug 2022

Mlcochova P, Kemp SA, Dhar MS, Papa G, Meng B, Ferreira IA, Datir R, Collier DA, Albecka A, Singh S (2021) SARS-CoV-2 B. 1.617. 2 Delta variant replication and immune evasion. Nature 599:114–119

Article  CAS  PubMed  PubMed Central  Google Scholar 

Coronavirus Disease 2019 (COVID-19) (2021) Treatment guidelines [Internet]. National Institutes of Health, Bethesda, MD

Google Scholar 

Hacisuleyman E, Hale C, Saito Y, Blachere NE, Bergh M, Conlon EG, Schaefer-Babajew DJ, DaSilva J, Muecksch F, Gaebler C (2021) Vaccine breakthrough infections with SARS-CoV-2 variants. N Engl J Med 384:2212–2218

Article  CAS  PubMed  Google Scholar 

Bhavnani D, James ER, Johnson KE, Beaudenon-Huibregtse S, Chang P, Rathouz PJ, Weldon M, Matouschek A, Young AE (2022) SARS-CoV-2 viral load is associated with risk of transmission to household and community contacts. BMC Infect Dis 22:1–11

Article  Google Scholar 

Poojary M, Shantaraman A, Jolly B, Scaria V (2020) Computational protocol for assembly and analysis of SARS-nCoV-2 genomes: assembly and analysis of SARS-nCoV-2 genomes. Research Reports 4

Planas D, Veyer D, Baidaliuk A, Staropoli I, Guivel-Benhassine F, Rajah MM, Planchais C, Porrot F, Robillard N, Puech J (2021) Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralization. Nature 596:276–280

Article  CAS  PubMed  Google Scholar 

Ujjainiya R, Tyagi A, Sardana V, Naushin S, Bhatheja N, Kumar K, Barman J, Prakash S, Kutum R, Bhaskar AK (2022) High failure rate of ChAdOx1-nCoV19 immunization against asymptomatic infection in healthcare workers during a Delta variant surge. Nat Commun 13:1726

Article  CAS  PubMed  PubMed Central  Google Scholar 

Voysey M, Clemens SAC, Madhi SA, Weckx LY, Folegatti PM, Aley PK, Angus B, Baillie VL, Barnabas SL, Bhorat QE (2021) Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK. Lancet 397:99–111

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lopez Bernal J, Andrews N, Gower C, Gallagher E, Simmons R, Thelwall S, Stowe J, Tessier E, Groves N, Dabrera G (2021) Effectiveness of Covid-19 vaccines against the B. 1.617. 2 (Delta) variant. N Engl J Med 385:585–594

Article  PubMed  Google Scholar 

16th National Technical Advisory Group on Immunization (NTAGI) Meeting (2021) https://main.mohfw.gov.in/sites/default/files/MoM%20NTAGI%20%20May%2028%2C%202021.pdf. Accessed 30 Aug 2022

Jung J, Kim JY, Park H, Park S, Lim JS, Lim SY, Bae S, Lim Y-J, Kim EO, Kim J (2022) Transmission and infectious SARS-CoV-2 shedding kinetics in vaccinated and unvaccinated individuals. JAMA Netw Open 5:e2213606–e2213606

Article  PubMed  PubMed Central  Google Scholar 

Mendonça SA, Lorincz R, Boucher P, Curiel DT (2021) Adenoviral vector vaccine platforms in the SARS-CoV-2 pandemic. NPJ Vaccines 6:97

Article  PubMed  PubMed Central  Google Scholar 

Ahi YS, Bangari DS, Mittal KS (2011) Adenoviral vector immunity: its implications and circumvention strategies. Curr Gene Ther 11:307–320

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hermosilla E, Coma E, Xie J, Feng S, Cabezas C, Méndez-Boo L, Fina F, Ballo E, Martínez M, Medina-Peralta M (2022) Comparative effectiveness and safety of homologous two-dose ChAdOx1 versus heterologous vaccination with ChAdOx1 and BNT162b2. Nat Commun 13:1639

Article  CAS  PubMed  PubMed Central  Google Scholar 

Purushotham JN, van Doremalen N, Munster VJ (2021) SARS-CoV-2 vaccines: anamnestic response in previously infected recipients. Cell Res 31:827–828

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ewer KJ, Barrett JR, Belij-Rammerstorfer S, Sharpe H, Makinson R, Morter R, Flaxman A, Wright D, Bellamy D, Bittaye M (2021) T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a phase 1/2 clinical trial. Nat Med 27:270–278

Article  CAS  PubMed  Google Scholar 

Ramasamy MN, Minassian AM, Ewer KJ, Flaxman AL, Folegatti PM, Owens DR, Voysey M, Aley PK, Angus B, Babbage G (2020) Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial. Lancet 396:1979–1993

Article  CAS  PubMed  PubMed Central  Google Scholar 

Revised guidelines for home isolation of mild/asymptomatic COVID-19 cases (2022) https://www.mohfw.gov.in/pdf/RevisedIllustratedGuidelinesforHomeIsolationofMildAsymptomaticCOVID19Cases.pdf. Accessed 30 Aug 2023